These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10096465)

  • 1. Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus.
    Endo A; Nagai N; Urano T; Takada Y; Hashimoto K; Takada A
    Neurosci Res; 1999 Jan; 33(1):1-8. PubMed ID: 10096465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection.
    Nagai N; Urano T; Endo A; Takahashi H; Takada Y; Takada A
    Neurosci Res; 1999 Feb; 33(2):147-54. PubMed ID: 10211780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.
    Endo A; Nagai N; Urano T; Ihara H; Takada Y; Hashimoto K; Takada A
    Neurosci Lett; 1998 Apr; 246(1):37-40. PubMed ID: 9622202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of the tissue plasminogen activator-plasmin system induced in the mouse hippocampus after injection of trimethyltin: possible proteolysis of highly polysialylated NCAM.
    Endo A; Hashimoto K; Takada Y; Takada A
    Jpn J Physiol; 1999 Oct; 49(5):463-6. PubMed ID: 10603431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.
    Tsirka SE; Gualandris A; Amaral DG; Strickland S
    Nature; 1995 Sep; 377(6547):340-4. PubMed ID: 7566088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus.
    Salles FJ; Strickland S
    J Neurosci; 2002 Mar; 22(6):2125-34. PubMed ID: 11896152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate.
    Wu YP; Siao CJ; Lu W; Sung TC; Frohman MA; Milev P; Bugge TH; Degen JL; Levine JM; Margolis RU; Tsirka SE
    J Cell Biol; 2000 Mar; 148(6):1295-304. PubMed ID: 10725341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.
    Chen ZL; Strickland S
    Cell; 1997 Dec; 91(7):917-25. PubMed ID: 9428515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus.
    Tsirka SE; Rogove AD; Bugge TH; Degen JL; Strickland S
    J Neurosci; 1997 Jan; 17(2):543-52. PubMed ID: 8987777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury.
    Indyk JA; Chen ZL; Tsirka SE; Strickland S
    Neuroscience; 2003; 116(2):359-71. PubMed ID: 12559092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
    Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
    J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
    Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
    Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
    Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
    J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.
    Zalfa C; Azmoon P; Mantuano E; Gonias SL
    J Leukoc Biol; 2019 Apr; 105(4):729-740. PubMed ID: 30690783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal actions of NCAM and tPA via a Ras-dependent MAPK activation in rat hippocampal neurons.
    Son H; Seuk Kim J; Mogg Kim J; Lee SH; Lee YS
    Biochem Biophys Res Commun; 2002 Oct; 298(2):262-8. PubMed ID: 12387826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
    Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
    Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
    Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
    J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
    Akassoglou K; Kombrinck KW; Degen JL; Strickland S
    J Cell Biol; 2000 May; 149(5):1157-66. PubMed ID: 10831618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.